Frankfurt/Main, 19.06.2024 – Funds advised by PINOVA Capital GmbH have acquired a majority stake in the Neuromedex Group, in a transaction that sees Neuromedex’s founder and another director reinvesting in the company. Hamburg-based Neuromedex is a leading supplier of single-use products for neurosurgery and intensive care medicine. Neuromedex products enable neurosurgeons to monitor and regulate intracranial pressure in their patients’ brains with minimal infection risk. PINOVA’s investment will mainly be used to drive the go-to-market of new innovative products and expansion of the international sales network.A CMS team led by partner Markus Herz advised PINOVA on all legal aspects of the transaction. PINOVA regularly relies on the expertise of CMS teams, including during the recent acquisition of Riepe GmbH & Co. KG. CMS Germany Markus Herz, Lead Partner Hanno Brandt, Senior Associate Lorenz Liebsch, Senior Associate Maxine Notstain, Senior Associate, all Corporate/M&A Philippe Heinzke, Partner Thomas Fröhlich, Counsel Lisa Dietrich, Associate Sara Kapur, Associate, all TMC Dr Mario Brungs, Counsel, Labor, Employment & Pensions Birgit Wagner, Legal Manager Julian Buhr, Legal Co­ordin­at­or Con­rad Gräwe, Legal Coordinator Shae Lynn Washington, Legal Co­ordin­at­or  Tag­rid Chahrour, Senior Legal Specialist Anke Clippingdale, Senior Legal Specialist, all Smart OperationsPress Con­tact presse@cms-hs. com

Frankfurt/Main, 19.06.2024 – The Finnish leading global technology group Valmet has signed a joint venture agreement with Körber, a leading international technology group based in Hamburg, to further strengthen FactoryPal. FactoryPal, a venture of Körber, is a provider of software developed for tissue converting operations that improves shopfloor manufacturing performance and productivity. The software empowers tissue mill teams to achieve seamless operations by generating and utilizing high quality data combined with state-of-the-art user experience and advanced AI. According to the joint venture agreement, Valmet will become the majority shareholder of FactoryPal, which will continue operating as an own legal entity under the existing brand. The set up of the joint venture is subject to customary closing conditions. The closing of the agreement is estimated to occur at earliest on August 1st, 2024. The joint venture follows Valmet’s acquisition of Körber’s Business Area Tissue that was completed in November 2023.A CMS team headed by lead partner Dr Peter Polke advised Valmet on all legal aspects of the joint venture. Valmet, headquartered in Espoo, Finland, is a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. With its automation systems and flow control solutions the company serves a wider base of process industries. Valmet’s shares are listed on the Nasdaq Helsinki. The company’s net sales in 2023 were approximately EUR 5.5 billion. Press Con­tact presse@cms-hs. com

Frankfurt/Main – The STAR IV Fund, which is advised by STAR Capital Partnership LLP, has acquired a majority stake in nextbike GmbH from Tier Mobility SE. nextbike is a leading developer and provider of innovative urban bike sharing solutions in Europe. STAR Capital is investing in nextbike alongside the management team. An international CMS team headed by lead partner Markus Herz advised STAR Capital on all legal aspects of the transaction. CMS Germany was supported by other CMS offices, including those in Spain, Poland, Sweden and Austria. Founded in 2004 and headquartered in Leipzig, nextbike provides public bike sharing schemes on behalf of transport authorities, cities and public institutions. The global company is currently active in more than 300 cities with a deployed fleet of around 115,000 bicycles. London-based STAR Capital Partnership LLP is a private equity firm investing in companies and assets with enterprise value between EUR 50 million and EUR 1 billion. CMS Germany Markus Herz, Lead Partner Dr Tobias Kilian, Of Counsel Dominik von Zehmen, Counsel Hanno Brandt, Senior Associate Lorenz Liebsch, Senior Associate, all Corporate/M&A Dr Boris Alles, Partner Dela Herr, Senior Associate, both Labor, Employment & Pensions  Dr Markus Pfaff, Partner Hatice Akyel, Counsel Till Komma, Counsel, all Banking & Finance Dr Thomas Hirse, Partner Thomas Fröhlich, Coun­sel Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Philippe Heinzke, Partner Sara Kapur, Associate, both TMC Julian Buhr, Legal Co­ordin­at­or Con­rad Gräwe, Legal Coordinator, both Smart Operations CMS Austria Florian Mayer, Partner Stefan Paulmayer, Partner Rebecca Herlitz, Associate CMS Poland Błażej Zagórski, Partner Piotr Stenko, Counsel Dr Magdalena Zmyslowska, Coun­sel Mag­dalena Piszewska, Senior As­so­ci­ate Krzysztof Sikora, Senior As­so­ci­ate Łukasz Duchiński, As­so­ci­ate Se­basti­an Łyś, As­so­ci­ate Wer­onika Burek CMS Spain Elena Alcázar Cuartero Jose Luis Díez Martín Ale­jandra Martin Benitez Paula Espinosa Montalbán Juan Moreno Alfonso Codes Calatrava CMS Sweden Henrik Aurelius, Counsel Noah Taha, AssociatePress Con­tact presse@cms-hs. com

Frankfurt/Main – The Alsatian family-owned group, De Dietrich Process Systems, acquires the Heinkel Group. Seller is the Dutch investor Stibbe Participaties. The Heinkel Group, with its recognized brands HEINKEL, COMBER, BOLZ-SUMMIX and JONGIA, is an international premium provider of solid-liquid separation solutions and drying and mixing systems, mainly for the pharmaceutical, chemical and food industries. Stibbe Participaties acquired the companies in 2005 after a turbulent time caused by a sharp downturn in the pharmaceutical industry and has developed Heinkel Group through add-on acquisitions to an international player in its sector. The combination of solid German management and hands-on support from Stibbe Participaties led to a revival of Heinkel – resulting in a strong market position and a stable recurring income from after sales and service. With the strategic merger of Heinkel Group and De Dietrich, De Dietrich enriches and broadens its portfolio and becomes a global leader in the fields of solid-liquid separation and the drying of active ingredients. An international CMS team headed by lead partner Dr Hendrik Hirsch advised Stibbe Participaties on all legal aspects of the transaction, including legal advice in more than seven jurisdictions (including Germany, the USA, Italy, the Netherlands, China, Singapore and India), legal support on the auction process and negotiation of contractual terms for the best possible integration of the Heinkel Group into the group of the successful bidder as the new owner as well as on tax and IP topics. Stibbe Participaties, based in Laren, Netherlands, is a family-held investor pursuing a buy-and-build strategy. The firm focuses on midsize industrial manufacturing companies with an experienced management and a position in a niche market with potential for market leadership. CMS Germany Dr Hendrik Hirsch, Lead Partner Maxine Notstain, Senior Associate, Co-Lead Markus Herz, Partner Dr Till Alexander von Poser, Associate, all Corporate/M&A Dr Hendrik Arendt, Senior Associate Dr Martin Friedberg, Partner, both Tax Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Till Komma, Counsel Lena Schauer, Associate, both Banking, Finance & Insurance Moritz Pottek, Counsel, Antitrust, Competition & Trade Tina Karakurt, Counsel Dr Franz Maurer, Counsel, both Real Estate & Public Dorothée Janzen, Partner, Com­mer­cial Birgit Wagner, Legal Manager, Smart Operations SMOP CMS Netherlands Pieter van Duijven­voorde Car­ola Bruijn Pieter de Kanter CMS Italy Daniela Murer Alessandra Cuni Sara TammarazioPress Con­tact presse@cms-hs. com

Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands. ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases. ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Jacob Siebert, Partner, Co-Lead Dr Dirk Baukholt, Principal Counsel Dr Berrit Roth-Mingram, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Roland Wiring, Partner Lukas Burgdorff, Associate Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Dr Michael Bauer, Partner Stefan Lehr, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel Dr. Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Dr Thomas de la Motte, Partner Dr Markus Pfaff, Partner Dr André Frischemeier, Partner Hatice Aykel, Counsel Alisa Brehm, Senior Associate Thomas Schaak, Senior Associate Dr Sait Dogan, Associate, all Banking & Finance  Dr André Lippert, Part­ner Con­stan­ze Schweidtmann, Associate, both Real Estate & Public Dr Boris Alles, Partner Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions CMS France Benoît Gomel, Partner Vincent Desbenoit, Associate Dylan Allali, all Corporate/M&A Caroline Froger-Michon, Partner Aurélie Parchet, As­so­ci­ate Ca­m­ille Baumgarten, Associate Sophie Yin, all Em­ploy­ment Claire Vannini, Partner Eleni Moraïtou, Coun­sel Lilia-Ori­ana Dif, Associate Ariane Rolin, all Competition & EU  Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, Associate, both Intellectual Property Laurine Mayer, Associate, TMC Alexandre Chazot, Counsel, Banking & Fin­ance  Thi­erry Granier, Partner Renaud Grob, Partner, both Tax Arnaud Valverde, Senior Associate, Real Estate Olivier Kuhn, Partner Cécile Rebiffé, Counsel Mylène Garrouste, all Dispute Res­ol­u­tion Kawthar Ben Khelil, Coun­sel Jean-Pierre Malili, Associate, both Public law/In­fra­struc­ture CMS Italy Massimo Trentino, Partner, Corporate/M&A Maria Letizia Patania, Partner, Lifescience & Healthcare Gian Marco Lettieri, Senior Associate, Employment & Pensions Giulio Poggioli, Counsel Valerio Giuseppe Daniele, As­so­ci­ate Francesca Durante, Junior As­so­ci­ate  Arianna Toccaceli, Junior Associate, all Banking & Finance CMS Luxembourg Gérard Maitrejean, Partner Miruna Poenaru, Coun­sel Max­imili­an Helfgen, Associate, all Corporate/M&A CMS UK Jack Letson, Partner Lindsay McAllister, Associate, both Corporate/M&A David Dennis, Partner, Commercial CMS Netherlands Pieter van Duijvenvoorde, Partner Robert Jong, both Corporate/M&A Nigel Henssen Fleur van Assendelft de Coningh, both Employment Edmon Oude Elferink, Partner Marijke van der Vossen, both Antitrust, Competition & Trade CMS Serbia Radivoje Petrikić, Partner Mila Drljević, both Corporate/M&A CMS Austria Dieter Zandler, Partner Vanessa Horaceck, both Competition & EU CMS Ukraine Maria Orlyk, Partner Diana Valyeyeva CMS Turkiye Döne Yalçın, Partner Arcan Kemahlı,  Sa­ba­hat­tin Öztemiz Taner ElmasPress Con­tact presse@cms-hs. com

Frankfurt/Main – German Equity Partners V (“GEP V” or the “Fund”) has taken an equity interest in the Düs­sel­dorf-based talent acquisition platform ONE HIRING Group (“1H”) through a partnership...

Frankfurt/Main – Funds advised by Pinova Capital, an independent private equity firm focusing on high-growth SMEs, have acquired Riepe GmbH & Co. KG from the owners, the Riepe family, by way of a management...

Frankfurt/Main – Funds advised by independent private equity firm Pinova Capital GmbH have acquired a majority stake in VTI Ventil Technik GmbH together with NRW. BANK. The seller is the AMX-listed...